# A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects

> **NCT02500667** · PHASE1 · COMPLETED · sponsor: **Nivalis Therapeutics, Inc.** · enrollment: 15 (actual)

## Conditions studied

- Drug Interaction Potentiation

## Interventions

- **DRUG:** N91115
- **DRUG:** Rifampin

## Key facts

- **NCT ID:** NCT02500667
- **Lead sponsor:** Nivalis Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2016-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02500667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02500667, "A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02500667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*